Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17823598 | 0.89 | P2RX3 (1.00) | P2RX3P2RX2 | |
| SCHEMBL29441164 | 0.89 | P2RX3 (1.00) | P2RX3P2RX2 | |
| SCHEMBL23396197 | 0.89 | P2RX3 (0.76) | P2RX3P2RX2 | |
| SCHEMBL25966110 | 0.86 | P2RX3 (1.00) | P2RX3P2RX2 | |
| SCHEMBL17823744 | 0.86 | P2RX3 (1.00) | P2RX3P2RX2 | |
| SCHEMBL29441217 | 0.86 | P2RX3 (1.00) | P2RX3P2RX2 | |
| SCHEMBL23396385 | 0.86 | P2RX3 (0.74) | P2RX3P2RX2 | |
| SCHEMBL22842731 | 0.86 | P2RX3 (0.81) | P2RX3P2RX2 | |
| SCHEMBL23396049 | 0.85 | P2RX3 (0.78) | P2RX3P2RX2 | |
| SCHEMBL23111445 | 0.85 | P2RX3 (1.00) | P2RX3P2RX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10174016-B2 | 1,3-thiazol-2-yl substituted benzamides | BEYER AKTIENGESELLSCHAFT (DE) | 2019-01-08 | — | — | US | disclosed |
| US-20180118731-A1 | 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180118731-A1 | 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES | NAT1, HNMT, PMP22 | P2RX3 578/4885P2RX2 541/4885 |
| US-10174016-B2 | 1,3-thiazol-2-yl substituted benzamides | NAT1, HNMT, PMP22 | P2RX3 578/4885P2RX2 541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.